 0001193125-17-048073.txt : 20170217 0001193125-17-048073.hdr.sgml : 20170217 20170217165432 accession number:		0001193125-17-048073 conformed submission type:	sc 13d public document count:		3 filed as of date:		20170217 date as of change:		20170217 group members:		garfinkle revocable trust group members:		morris garfinkle subject company:	 	company data:	 		company conformed name:			agritech worldwide, inc. 		central index key:			0001052257 		standard industrial classification:	grain mill products [2040] 		irs number:				364197173 		state of incorporation:			nv 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 		sec act:		1934 act 		sec file number:	005-78466 		film number:		17622070 	business address:	 		street 1:		1011 campus drive 		city:			mundelein 		state:			il 		zip:			60060 		business phone:		847-549-6002 	mail address:	 		street 1:		1011 campus drive 		city:			mundelein 		state:			il 		zip:			60060 	former company:	 		former conformed name:	z trim holdings, inc 		date of name change:	20060623 	former company:	 		former conformed name:	circle group holdings inc 		date of name change:	20030313 	former company:	 		former conformed name:	circle group internet inc 		date of name change:	19980512 filed by:		 	company data:	 		company conformed name:			kahn jonathan efrem 		central index key:			0000874581 		state of incorporation:			il 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 	business address:	 		street 1:		440 s. lasalle 		street 2:		ste. 1720 		city:			chicago 		state:			il 		zip:			60605 		business phone:		3123481443 	mail address:	 		street 1:		440 s. lasalle 		street 2:		ste. 1720 		city:			chicago 		state:			il 		zip:			60605 	former company:	 		former conformed name:	kahn jonathan efrem /il/ /bd 		date of name change:	19930721 sc 13d 1 d353249dsc13d.htm sc 13d sc 13d united states securities and exchange commission washington, d. c. 20549 schedule 13d under the securities exchange act of 1934 (amendment no. )* agritech worldwide, inc. (name of issuer) common stock, par value $0.00005 per share (title of class of securities) 988924205 (cusip number of class of securities) morris garfinkle jonathan kahn c/o agritech worldwide, inc. 1011 campus drive mundelein, illinois 60060 (847) 549-6028 garfinkle revocable trust 13783 e. gail rd. scottsdale, az 85259 (202) 359-2107 (name, address and telephone number of person authorized to receive notices and communications) february 17, 2017 (date of event which requires filing of this statement) if the filing person has previously filed a statement on schedule 13g to report the acquisition that is the subject of this schedule 13d and is filing this schedule because of rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. &#9744; note: schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. see rule 240.13d-7(b) for other parties to whom copies are to be sent. * the remainder of this cover page shall be filled out for a reporting person&#146;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. the information required on the remainder of this cover page shall not be deemed to be &#147;filed&#148; for the purpose of section 18 of the securities exchange act of 1934 (&#147;act&#148;) or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act (however, see the notes). cusip no. 988924205 schedule 13d page 2 of 10 1. name of reporting person: morris garfinkle 2. check the appropriate box if a member of a group (a) &#9746; (b) &#9744; 3. sec use only 4. source of funds pf; oo 5. check box if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) &#9744; 6. citizenship or place of organization united states number of shares beneficially owned by each reporting person with 7. sole voting power 8,684,233 8. shared voting power 628,652 9. sole dispositive power 8,684,233 10. shared dispositive power 628,652 11. aggregate amount beneficially owned by each reporting person 9,312,885 12. check box if the aggregate amount in row (11) excludes certain shares &#9744; 13. percent of class represented by amount in row (11) 6.0% 14. type of reporting person in cusip no. 988924205 schedule 13d page 3 of 10 1. name of reporting person: garfinkle revocable trust 2. check the appropriate box if a member of a group (a) &#9746; (b) &#9744; 3. sec use only 4. source of funds oo 5. check box if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) &#9744; 6. citizenship or place of organization arizona number of shares beneficially owned by each reporting person with 7. sole voting power 0 8. shared voting power 628,652 9. sole dispositive power 0 10. shared dispositive power 628,652 11. aggregate amount beneficially owned by each reporting person 628,652 12. check box if the aggregate amount in row (11) excludes certain shares &#9744; 13. percent of class represented by amount in row (11) 0.4% 14. type of reporting person oo cusip no. 988924205 schedule 13d page 4 of 10 1. name of reporting person: jonathan kahn 2. check the appropriate box if a member of a group (a) &#9746; (b) &#9744; 3. sec use only 4. source of funds pf; oo 5. check box if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) &#9744; 6. citizenship or place of organization united states number of shares beneficially owned by each reporting person with 7. sole voting power 7,783,663 8. shared voting power 0 9. sole dispositive power 7,783,663 10. shared dispositive power 0 11. aggregate amount beneficially owned by each reporting person 7,783,663 12. check box if the aggregate amount in row (11) excludes certain shares &#9744; 13. percent of class represented by amount in row (11) 5.009% 14. type of reporting person in schedule 13d item 1. security and issuer this schedule 13d (&#147; statement &#148;) relates to shares of common stock (as defined below). the principal executive offices of agritech worldwide, inc., a nevada corporation (the &#147; company &#148;), are located at 1011 campus drive, mundelein, illinois 60060. this statement also constitutes an amendment to each of the following (as and to the extent applicable): (i) the statement of beneficial ownership on schedule 13d filed by mr. garfinkle (as defined below) with the securities and exchange commission (&#147; sec &#148;) on june 30, 2016 (the &#147; prior garfinkle 13d &#148;) and (ii) the statement of beneficial ownership on schedule 13d filed by mr. kahn (as defined below) with the sec on may 27, 2016 (the &#147; prior kahn 13d &#148; and collectively with the prior garfinkle 13d, the &#147; prior 13d filings &#148;)). &#147; common stock &#148; means shares of common stock, par value $0.00005 per share, of the company. the reporting persons intend to file jointly until such time as they cease to be deemed a &#147;group&#148; (as such term is defined under the securities exchange act of 1934, as amended, and the rules and regulations promulgated thereunder by the sec). item 2. identity and background (a) the persons filing this statement are morris garfinkle, (&#147; mr. garfinkle &#148;), the garfinkle revocable trust (the &#147; revocable trust &#148;) and jonathan kahn (&#147; mr. kahn &#148;) (collectively, the &#147; reporting persons &#148;). this statement also relates to debt instruments of the company held by (i) mr. kahn, (ii) mr. garfinkle, (iii) the revocable trust and (iv) gks funding llc, a limited liability company controlled and equally owned by mr. kahn and mr. garfinkle (&#147; gks funding &#148;). mr. garfinkle serves as a co-trustee of the revocable trust. mr. garfinkle, in his capacity as co-trustee, and the other co-trustee each exercises voting and investment power over the shares of common stock held for the account of the revocable trust. (b) the business address of each of mr. garfinkle and mr. kahn is c/o agritech worldwide, inc., 1011 campus drive, mundelein, illinois 60060. the business address of the revocable trust is 13783 e. gail rd., scottsdale, az 85259. (c) mr. kahn&#146;s principal occupation is serving as the chief executive officer of the company. the business address of the company is 1011 campus drive, mundelein, illinois 60060. the company is an agritech company that owns existing, and seeks to develop new, products and processes that convert generally available agricultural by-products into multi-functional all-natural ingredients that can be used in food manufacturing and other industries. the principal occupation of mr. garfinkle is serving as the founder, chairman and ceo of tailwind consultants, llc (&#147; tailwind &#148;), which is a privately-owned consulting company. the business address of tailwind is 13783 e. gail rd., scottsdale, az 85259. the revocable trust is a private revocable trust created by mr. garfinkle and his wife for estate planning purposes. the business address of the revocable trust is 13783 e. gail rd., scottsdale, az 85259. (d) none of the reporting persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) none of the reporting persons has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which such reporting person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) each of mr. garfinkle and mr. kahn is a citizen of the united states of america. the revocable trust is trust governed by the laws of arizona. item 3. source and amount of funds or other consideration no funds were used by mr. kahn in acquiring the 900,000 shares of common stock reported herein in item 4 in exchange for the warrants of the company held by mr. kahn or the 415,732 shares of common stock described in clause (z) of item 5(a)(i). $249,000 was contributed by mr. kahn from his personal funds to gks funding and was used by gks funding to acquire $249,000 of the note described in item 4 below. no funds were used by mr. garfinkle in acquiring the 5,563,574 shares of common stock reported herein in item 4 in exchange for the warrants of the company held by mr. garfinkle. $249,000 was contributed by mr. garfinkle from his personal funds to gks funding and was used by gks funding to acquire $249,000 of the note described in item 4 below. no funds were used by the revocable trust in acquiring the 459,449 shares of common stock reported herein in item 4 in exchange for the warrants of the company held by the revocable trust. item 4. purpose of transaction in late november 2016, mr. kahn and mr. garfinkle began having discussions regarding potential alternatives with respect to the company&#146;s ongoing debt and equity financing needs, which ultimately culminated in the loan agreement (as defined below) and the term sheet (as defined below). on december 12, 2016, mr. kahn entered into an exchange agreement with the company pursuant to which mr. kahn exchanged warrants to purchase 900,000 shares of common stock for 900,000 shares of common stock. following such exchange, mr. kahn ceased to hold any warrants issued by the company. on december 12, 2016, mr. garfinkle entered into an exchange agreement with the company pursuant to which mr. garfinkle exchanged warrants to purchase 5,563,574 shares of common stock for 5,563,574 shares of common stock. following such exchange, mr. garfinkle ceased to hold any warrants issued by the company. on december 12, 2016, the revocable trust entered into an exchange agreement with the company pursuant to which the revocable trust exchanged warrants to purchase 459,449 shares of common stock for 459,449 shares of common stock. following such exchange, the revocable trust ceased to hold any warrants issued by the company. the foregoing description is qualified in its entirety by reference to the exchange agreement, which was filed as exhibit 10.1 to the company&#146;s current report on form 8-k filed with the sec on december 14, 2016 (the &#147; december 8-k filing &#148;), and is hereby incorporated herein by reference. as disclosed by the company on current report on form 8-k filed with the sec on february 6, 2017 (the &#147; february 8-k filing &#148;), the company entered into a loan and security agreement (the &#147; loan agreement &#148;) with various lenders (which included gks funding) and issued a note in connection therewith in the original principal amount of $996,000 (the &#147; note &#148;). the note accrues interest at a rate per annum equal to the prime rate plus 18.9%. interest is payable monthly and the principal is payable on the maturity date of the note, which is 2.5 years from the issuance date. such loan is secured by all of the assets of the company. the loan agreement contains certain covenants regarding financial reporting, limits on the company&#146;s incurrence of indebtedness, permitted investments, encumbrances, restricted payments and mergers and acquisitions. the loan agreement also includes customary events of default, including non-payment by the company of the monthly interest payments and the payment of penalties upon such late payments. a portion of the proceeds of such loan were used by the company to exercise its purchase option under its equipment lease agreement with fordham capital partners, llc that it entered into on july 17, 2015. the remaining proceeds of such loan are intended to be utilized by the company for working capital purposes. as a condition to the loan agreement, two directors of the company that held senior secured debt of the company entered into a subordination agreement with the company and the administrative agent for the lenders (the &#147; subordination agreement &#148;). the term sheet (as defined below) contemplates that the note (which is 50% indirectly held by mr. kahn and mr. garfinkle as described above through gks funding) would be exchanged on a dollar-for-dollar basis for the newly-created preferred stock described in the term sheet. the foregoing descriptions of the of the loan agreement, the note and the subordination agreement are qualified in their entirety by reference to the loan agreement, the note and the subordination agreement, which were filed as exhibits 10.1, 10.2 and 10.3 to the february 8-k filing and are hereby incorporated herein by reference. following the close of business on february 17, 2017, the reporting persons delivered a term sheet for proposed convertible preferred financing, which is attached hereto as exhibit a (the &#147; term sheet &#148;), to the company relating to the potential acquisition of shares of a newly-created series of preferred stock of the company. as proposed, such newly-created preferred stock would be convertible into approximately 75% of the company (on a fully-diluted basis) and would be entitled, as a class, to designate 3 of the 5 directors of the company. the foregoing description of the term sheet is qualified in its entirety by reference to the term sheet, which is attached hereto as exhibit a , and is hereby incorporated herein by reference. each reporting person expects to evaluate on an ongoing basis the company&#146;s financial condition and prospects and its interest in, and intentions with respect to, the company and their investment in the securities of the company, which review may be based on various factors (including, without limitation, the company&#146;s business and financial condition, results of operations and prospects, general economic and industry conditions, the price and availability of shares of the company&#146;s capital stock, the conditions of the securities markets in general and those for the company&#146;s securities in particular), as well as other developments and other investment opportunities. accordingly, each reporting person reserves the right to change its intentions, as it deems appropriate. in particular, each reporting person may at any time and from time to time, in the open market, in privately negotiated transactions or otherwise, increase their investment in securities of the company or dispose of all or a portion of the securities of the company that such reporting persons now owns or may hereafter acquires. in addition, the reporting persons may engage in discussions with other members of management and other members of the board of directors of the company regarding the company (including, but not limited to, the company&#146;s business and financial condition, results of operations and prospects). the reporting persons may take positions with respect to and seek to influence the company regarding the matters discussed above. such suggestions or positions may include one or more plans or proposals that relate to or would result in any of the actions required to be reported herein. the reporting persons also reserve the right, in each case subject to applicable law, to (i) enter into privately negotiated derivative transactions with institutional counterparties to hedge the market risk of some or all of their positions in the shares of common stock or other securities and (ii) consider participating in a business combination transaction that would result in an acquisition of all of the outstanding common stock. other than as described above in this item 4, the reporting persons do not have any plans or proposals that relate to, or would result in, any actions or events specified in clauses (a) through (j) of item 4 to schedule 13d. item 5. interest in securities of the issuer 154,976,459 shares of common stock were issued and outstanding as of february 17, 2017. (a) (i) as of the close of business on february 17, 2017, mr. kahn may have been deemed to have beneficial ownership of 7,783,663 shares of common stock, consisting of (x) 6,467,931 shares of common stock held by mr. kahn, (y) the 900,000 shares of common stock issued to mr. kahn in exchange for mr. kahn&#146;s warrants as described above in item 4 and (z) 415,732 shares of common stock that were required to be issued to mr. kahn prior to the date hereof pursuant to section 3(c)(iv) of the kahn employment agreement (as defined in the prior kahn 13d), and all such 7,783,663 shares of common stock represented beneficial ownership of approximately 5.009% of the common stock. (ii) as of the close of business on february 17, 2017, mr. garfinkle may have been deemed to have beneficial ownership of 9,312,885 shares of common stock, consisting of (i) 3,024,608 shares of common stock held by mr. garfinkle, (ii) the 5,563,574 shares of common stock issued to mr. garfinkle in exchange for warrants held by mr. garfinkle as described above in item 4, (iii) the 459,449 shares of common stock issued to the revocable trust in exchange for warrants held by the revocable trust as described above in item 4, (iv) 96,051 shares of common stock issuable upon conversion of 5,210 shares of series b preferred stock of the company held by mr. garfinkle as described in the prior garfinkle 13d, (v) 89,858 shares of common stock issuable upon conversion of 4,874 shares of series b preferred stock of the company held by the revocable trust as described in the prior garfinkle 13d and (vi) 79,345 shares of common stock issuable upon conversion of a convertible note held by the revocable trust that was described in the prior garfinkle 13d, 1 and all such 9,312,885 shares of common stock represented beneficial ownership of approximately 6.0% of the common stock. the foregoing excludes 1,006,711 shares of common stock issuable upon exercise of options that were issued to mr. garfinkle because such options are not exercisable until they fully vest on may 17, 2017. (iii) as of the close of business on february 17, 2017, the revocable trust may have been deemed to have beneficial ownership of 628,652 shares of common stock, consisting of (i) the 459,449 shares of common stock issued to the revocable trust in exchange for warrants held by the revocable trust as described above in item 4, (ii) 89,858 shares of common stock issuable upon conversion of 4,874 shares of series b preferred stock of the company held by the revocable trust as described in the prior garfinkle 13d and (iii) 79,345 shares of common stock issuable upon conversion of a convertible note held by the revocable trust that was described in the prior garfinkle 13d, and all such 628,652 shares of common stock represented beneficial ownership of approximately 0.4% of the common stock. (b) (i) as of the close of business on february 17, 2017, mr. kahn may have been deemed to have the sole power to vote and direct the disposition of 7,783,663 shares of common stock, consisting of (x) 6,467,931 shares of common stock held by mr. kahn, (y) the 900,000 shares of common stock issued to mr. kahn in exchange for mr. kahn&#146;s warrants as described above in item 4 and (z) 415,732 shares of common stock that were required to be issued to mr. kahn prior to the date hereof pursuant to section 3(c)(iv) of the kahn employment agreement, and all such 7,783,663 shares of common stock represented beneficial ownership of approximately 5.009% of the common stock. (ii) as of the close of business on february 17, 2017, mr. garfinkle may have been deemed to have (i) the sole power to vote and direct the disposition of 8,684,233 shares of common stock, consisting of (1) 3,024,608 shares of common stock held by mr. garfinkle, (2) the 5,563,574 shares of common stock issued to mr. garfinkle in exchange for warrants held by mr. garfinkle as described above in item 4 and (3) 96,051 shares of common stock issuable upon conversion of 5,210 shares of series b preferred 1 such convertible note (which was referred to as the $75,000 note in the prior garfinkle 13d) has always been held by the revocable trust and not directly by mr. garfinkle. stock of the company held by mr. garfinkle as described in the prior garfinkle 13d and (ii) the shared power to vote and direct the disposition of 628,652 shares of common stock, consisting of (i) the 459,449 shares of common stock issued to the revocable trust in exchange for warrants held by the revocable trust as described above in item 4, (ii) 89,858 shares of common stock issuable upon conversion of 4,874 shares of series b preferred stock of the company held by the revocable trust as described in the prior garfinkle 13d and (iii) 79,345 shares of common stock issuable upon conversion of a convertible note held by the revocable trust that was described in the prior garfinkle 13d, and all such 9,312,885 shares of common stock represented beneficial ownership of approximately 6.0% of the common stock. the foregoing excludes 1,006,711 shares of common stock issuable upon exercise of options that were issued to mr. garfinkle because such options are not exercisable until they fully vest on may 17, 2017. (iii) as of the close of business on february 17, 2017, the revocable trust may have been deemed to have the shared power to vote and direct the disposition of 628,652 shares of common stock, consisting of (i) the 459,449 shares of common stock issued to the revocable trust in exchange for warrants held by the revocable trust as described above in item 4, (ii) 89,858 shares of common stock issuable upon conversion of 4,874 shares of series b preferred stock of the company held by the revocable trust as described in the prior garfinkle 13d and (iii) 79,345 shares of common stock issuable upon conversion of a convertible note held by the revocable trust that was described in the prior garfinkle 13d, and all such 628,652 shares of common stock represented beneficial ownership of approximately 0.4% of the common stock. (c) except as described in item 4 above and clause (z) of item 5(a)(i) above, (i) the revocable trust had no transactions in the common stock during the 60 days preceding the date of filing of this statement, (ii) mr. kahn had no transactions in the common stock since the filing of the prior kahn 13d and (iii) mr. garfinkle had no transactions in the common stock since the filing of the prior garfinkle 13d. all of such shares of common stock described in item 4 above and in clause (z) of item 5(a)(i) above so acquired by the respective reporting persons were acquired by each of the respective reporting persons directly from the company. (d) other than the co-trustee of the revocable trust and the beneficiaries of the revocable trust, in each case, with respect to the revocable trust, no other person is known by the reporting persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any shares of common stock that are beneficially owned by the reporting persons. item 6. contracts, arrangements, understandings or relationships with respect to the securities of the issuer pursuant to rule 13d-1(k)(1) promulgated under the securities exchange act of 1934, as amended, the reporting persons have entered into an agreement with respect to the joint filing of this statement, and any amendment or amendments hereto. item 4 is incorporated in this item 6 by reference. except as otherwise described in items 4 and 6 of this statement and the prior 13d filings, no contracts, arrangements, understandings or similar relationships exist with respect to the securities of the company among or among the reporting persons or any other person or entity. item 7. material to be filed as exhibits exhibit no. description 99.1 joint filing agreement, dated as of february 17, 2017, among the reporting persons. exhibit a term sheet for proposed convertible preferred financing exhibit 10.1 exchange agreement* exhibit 10.1 loan agreement** exhibit 10.2 note** exhibit 10.3 subordination agreement** * filed as an exhibit to the december 8-k filing, which was filed by the company with the sec on december 14, 2016. ** filed as exhibits to the february 8-k filing, which was filed by the company with the sec on february 6, 2017. signature after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete and correct. dated: february 17, 2017 /s/ morris garfinkle morris garfinkle /s/ jonathan kahn jonathan kahn garfinkle revocable trust /s/ morris garfinkle morris garfinkle, co-trustee exhibit index exhibit no. description 99.1 joint filing agreement, dated as of february 17, 2017, among the reporting persons. exhibit a term sheet for proposed convertible preferred financing exhibit 10.1 exchange agreement* exhibit 10.1 loan agreement** exhibit 10.2 note** exhibit 10.3 subordination agreement** * filed as an exhibit to the december 8-k filing, which was filed by the company with the sec on december 14, 2016. ** filed as exhibits to the february 8-k filing, which was filed by the company with the sec on february 6, 2017. ex-99.1 2 d353249dex991.htm ex-99.1 ex-99.1 exhibit 99.1 joint filing agreement in accordance with rule 13d-1(k), as promulgated under the securities exchange act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a statement on schedule 13d (including amendments thereto) with regard to the common stock of agritech worldwide, inc. and further agree that this joint filing agreement be included as an exhibit to such joint filings. in evidence thereof, the undersigned, being duly authorized, hereby execute this joint filing agreement as of february 17, 2017. dated: february 17, 2017 /s/ morris garfinkle morris garfinkle /s/ jonathan kahn jonathan kahn garfinkle revocable trust /s/ morris garfinkle morris garfinkle, co-trustee ex-99.a 3 d353249dex99a.htm ex-99.a ex-99.a agritech worldwide, inc. term sheet for proposed convertible preferred financing february 17, 2017 this term sheet summarizes the principal terms of a proposed convertible preferred equity financing of agritech worldwide, inc., a nevada corporation (the &#147; company &#148;). the securities issued to the investors (as defined below) will have the characteristics, terms, and provisions described in this term sheet. in consideration of the time, effort and expense devoted and to be devoted by the investors and the company with respect to the investment contemplated by this term sheet (the &#147; transaction &#148;), the no shop, good faith efforts, governing law and expenses provisions in the &#147;other matters&#148; section of this term sheet shall be binding and enforceable obligations of the parties named therein, whether or not the transaction is ultimately consummated. no other legally binding or enforceable agreements or obligations are intended to be, or are, created under this term sheet, and no such binding or enforceable agreement shall be deemed created other than pursuant to the execution and delivery of written, definitive and binding agreements by the parties. this term sheet is not a commitment to invest and is conditioned on documentation satisfactory to the investors. investment terms closing date &amp; document preparation: the sale and issuance of the company&#146;s new convertible preferred stock (the &#147; new preferred &#148;) will be consummated at a closing (the &#147; closing &#148;) on the day that the parties execute and deliver the definitive purchase and other agreements and satisfy the conditions to the closing specified therein, which is anticipated to be no later than 60 days after the execution of this term sheet. issuer: agritech worldwide, inc. investors: morris garfinkle, jonathan kahn and/or their respective affiliates and other third party accredited investors aggregate offering: the aggregate offering will be for the issuance and sale of up to $6,000,000 of new preferred, but not less than $4,000,000. investment timing: the investment amount will be funded at the closing. securities: series c convertible preferred stock, the terms of which are set forth herein. pre-money valuation: the price per new preferred unit (the &#147; original purchase price &#148;) will be based upon a fully-diluted pre-money valuation of the company of $3,529,751 (taking into account all anti-dilution adjustments) and a fully-diluted post-money valuation of the company of up to $9,529,751. the price per new preferred share shall be $1.00 (the &#147; original purchase price &#148;). capitalization: the company&#146;s capital structure and capital ownership, after giving effect to the new preferred and the &#147;restructuring&#148; described herein, is set forth in the post-closing capitalization table attached as exhibit a hereto. use of funds: the net proceeds of the transaction will be used for the repayment of a portion of the face value of the &#147;notes&#148; (as defined below) pursuant to the restructuring (as defined below) and working capital, product development and other general corporate purposes. purchase &amp; sale of new preferred definitive agreement: the purchase and sale of new preferred shall be effected pursuant to a securities purchase agreement (the &#147; purchase agreement &#148;) between the investors and the company, to reflect the terms and provisions in this term sheet and to be in form and substance acceptable to the investors. representations and warranties: the purchase agreement will include (i) customary representations and warranties, including due authorization, valid issuance, absence of conflicts, operations and financial position from the company and (ii) customary investment representations from the investors. 2 conditions: the purchase agreement will include standard conditions to closing, including, among others, completion of financial and legal due diligence with results satisfactory to each investor in its sole discretion, an independent fairness opinion conducted by an investment bank satisfactory to investors, approval of the transaction by an independent committee of the company formed for the purpose of evaluating and approving all of the transactions contemplated hereby and an opinion of counsel to the company and the amendment to the company&#146;s certificate of incorporation authorizing and establishing the rights, preferences, and limitations of the new preferred as set forth in this term sheet. additionally, concurrent with closing, (i) the $996,000 note entered into by the company pursuant to that certain loan and security agreement dated as of february 1, 2017 by and between the company, susan a. stone, roger stone and gks funding llc will be exchanged for shares of new preferred contemporaneous with the issuance thereof to the investors on a dollar-for-dollar basis (with all accrued but unpaid interest thereon being paid in cash), (ii) all existing promissory notes (the &#147; notes &#148;) shall have been repaid and/or converted to common stock on terms consistent with exhibit a and acceptable to the investors in their sole discretion and (iii) the terms of the series b preferred stock (the &#147; existing preferred &#148;) shall have been amended on terms acceptable to the investors in their sole discretion (collectively, the &#147; restructuring &#148;). draft agreements: greenberg traurig, llp will prepare substantially all of the documents necessary to complete the transaction subject to review by company&#146;s counsel (in each case at the company&#146;s expense). terms of the new preferred liquidation preference: in connection with any sale, liquidation, dissolution, winding up or any sale of the company (however structured) prior to conversion of the new preferred, the holders of new preferred shall be entitled to receive, out of the proceeds therefrom available for distribution to the company&#146;s equity holders and prior to any other distribution of proceeds in respect of the company&#146;s other equity securities, an amount equal to 2x the original purchase price for such holder&#146;s new preferred. thereafter, the new preferred shall participate in any remaining proceeds on an as-if converted basis. dividends: the new preferred shall participate in dividends made to the holders of common stock on an as-converted basis. 3 conversion: the new preferred shall be convertible into the company&#146;s common stock (&#147; common stock &#148;), at the option of each holder thereof, without the payment of additional consideration at any time or from time to time. the new preferred shall automatically convert to common stock at such time as a majority of the new preferred in the aggregate is converted to common stock. the total number of shares of common stock into which the new preferred may be converted initially will be determined by dividing the original purchase price by the conversion price. the initial conversion price will be set such that the new preferred is convertible into 75% of the company&#146;s fully-diluted shares outstanding (determined as of the closing). the conversion price of the new preferred will be subject to adjustment as provided below under anti-dilution protection . anti-dilution protection: in addition to normal and customary anti-dilution protections ( e.g ., proportional adjustment for stock splits, stock dividends, combinations, and similar events), in the event that the company issues additional equity securities (or securities convertible into or exchangeable or exercisable for equity securities) at a purchase price that is less than the then-current new preferred conversion price, then, unless otherwise waived by the holders of a majority of the new preferred (&#147; new preferred majority &#148;), the conversion price will be reduced to the purchase price for such securities (subject to customary exceptions for issuances pursuant to a board approved equity incentive plan, issuances upon conversion of existing securities or securities issued in the future for which an anti-dilution adjustment has previously been made and equity issued as consideration for permitted acquisitions). redemption: the new preferred shall be redeemable at the option of each holder thereof, commencing any time after the 5th anniversary of the closing at a price equal to the greater of (i) 2x the original purchase price and (ii) the fair market value thereof (the &#147; redemption price &#148;). voting rights: the new preferred shall vote together with the common stock on an as-if converted basis, and not as a separate class, on all matters submitted to a vote of members, except (i) the new preferred majority shall be entitled to elect 3 of the 5 members of the board (the &#147; new preferred directors &#148;), (ii) as provided under &#147; protective provisions &#148; below and (iii) as required by law. protective provisions: the company shall not take any of the following actions without the separate vote or separate written consent of the board and at least one of the new preferred directors or the new preferred majority; (i) amend the company&#146;s constitutive or other documents of the company so as to adversely affect the rights, preferences and privileges of the holders of new preferred or the new preferred directors; 4 (ii) authorize, designate, create or issue, whether by reclassification or otherwise, any additional equity securities of the company or any securities convertible into, or exchangeable or exercisable for equity securities of the company senior to or pari passu with the new preferred; (iii) increase or decrease the authorized number of new preferred or issue any additional new preferred; (iv) declare or pay any dividends on or make other distributions with respect to any securities of the company or any of its subsidiaries; (v) redeem, repurchase or otherwise acquire any securities of the company (other than (i) the repurchase by the company of employee incentive stock from terminated employees pursuant to agreements that have been approved by the board or (ii) any redemption of the new preferred as contemplated herein; (vi) enter into any transaction between the company or any of its subsidiaries on the one hand, and any founder, officer, director or material equity holder (or any affiliate or family member thereof) of the company or any of its subsidiaries on the other hand; (vii) acquire the operations, assets (other than loans) or equity interest of another business through any form, including by merger, consolidation, license, lease or the purchase of assets of securities other than the purchase or lease of equipment, goods and supplies in the ordinary course of business; (ix) change the principal business of the company, enter new lines of business, or exit the current line of business; or (x) take any action that commits the company or any of its subsidiaries to do any of the foregoing 5 investors rights terms board of directors matters: each board committee and each board and committee of each subsidiary of the company shall include at least one new preferred director designated by a majority of the new preferred directors then in office. the company will bind d&amp;o insurance with a carrier and in an amount reasonably satisfactory to investors. the company&#146;s and each of its subsidiaries&#146; constitutive documents will contain customary provisions for the indemnification of directors and the advancement of expenses in connection with claims. in the event the company merges with another entity and is not the surviving corporation, or transfers all of its assets, proper provisions shall be made so that successors of the company assume the company&#146;s obligations with respect to indemnification of directors. the company or the applicable subsidiary shall pay or reimburse the reasonable out-of-pocket expenses incurred by the new preferred directors and observers in attending meetings of the board, any committees of the board, and any board or committee meetings of any subsidiary. information rights: if at any time, the company is no longer an sec reporting company, each holder of 15% or more of the new preferred or common stock into which such new preferred has been converted will be granted access to company facilities and personnel during normal business hours and following reasonable advance notice. in addition, if at any time, the company is no longer an sec reporting company, the company will deliver to such holders (i) annual and quarterly financial statements, and other information as reasonably requested by such holders; (ii) thirty days prior to the end of each fiscal year, a comprehensive operating budget forecasting the company&#146;s revenues, expenses, and cash position on a month to month basis for the upcoming fiscal year; and (iii) promptly following the end of each quarter an up-to-date capitalization table. right of first refusal: the investors shall have a right of first refusal for all subsequent financings undertaken by the company for so long as any of the new preferred remains outstanding. 6 events of noncompliance: in the event that (a) the company breaches any of its representations and warranties made to the investors, (b) the company incurs a material unsatisfied judgment, (c) the company incurs a material unpaid acceleration of debt, (d) any shares of the common stock are suspended or cease trading for twenty (21) consecutive days or for more than fifteen (15) trading days in any 365-day year (unless the company is no longer a reporting company), (e) there is less than 100% of the number of shares of common stock needed to satisfy the number of shares of common stock the holders of the new preferred would receive if all shares of the new preferred were converted at the conversion price then in effect, (f) the company fails to pay any amount owed to the holders of the new preferred or (g) the company incurs a bankruptcy or insolvency event, then during the continuation thereof, at the election of each holder of the new preferred (or automatically in the case of a bankruptcy event) such holder&#146;s new preferred shall become redeemable (or shall immediately be redeemed, in the base of a bankruptcy event) for a price equal to the redemption price. registrable securities: common stock or other securities which may be issuable upon conversion or exchange of the new preferred and any other equity securities held by the investors will be deemed &#147; registrable securities .&#148; demand registration: at any time or from time to time, persons holding at least a majority of the registrable securities may request (consummated) registrations by the company of their registrable securities in which event all holders of registrable securities will be entitled to participate pro-rata; provided that (i) the company shall only be obligated to consummate one such registration in any 12-month period and (ii) the company shall not be obligated to register registrable securities having a reasonably anticipated offering price of less than $500,000 in the aggregate. registration on form s-3: the holders of at least a majority of the registrable securities will have the right to require the company to register their registrable securities on form s-3, if available for use by the company, in which event all holders of registrable securities will be entitled to participate pro-rata. there will be no limit on the aggregate number of such form s-3 registrations, provided that there are no more than two per year. 7 piggyback registration: the holders of registrable securities will be entitled to &#147;piggyback&#148; registration rights on all registration statements of the company, subject to the right, however, of the company and its underwriters to reduce the amount of securities proposed to be registered to a minimum of 20% on a pro rata basis and to complete reduction on an ipo at the underwriter&#146;s discretion. in all events, the securities to be registered by holders of registrable securities will be reduced only after all other equity holders&#146; securities are reduced. registration expenses: the registration expenses (exclusive of stock transfer taxes, underwriting discounts and commissions) will be borne by the company. the company will also pay the reasonable fees and expenses of one special counsel to represent all the participating holders of registrable securities. no other registration rights: no future registration rights may be granted without consent of the holders of a majority of the registrable securities unless subordinate to the holders of registrable securities rights. amendment to prior round terms: as a condition to the consummation of the purchase of the new preferred, the terms relating to the existing preferred shall be amended to eliminate all special economic, voting or approval rights, restrictive covenants or similar rights, such that the existing preferred becomes pari passu with the common stock (with the exception of approval rights in respect of amendments to the company&#146;s constitutive documents which disproportionately and adversely affect the existing preferred, which in no event shall include the creation or issuance of additional classes or series of equity securities). other matters no shop: the company agrees that it will not, and the company will cause its representatives, officers, managers, members, advisors, affiliates and agents not to, for a period of 60 days following the date these terms are accepted (the &#147; standstill period &#148;), take any action to solicit, initiate, encourage or assist the submission of any proposal, negotiation or offer from any person or entity, relating to the sale or issuance of any of the debt or equity securities of the company or any options, warrants or instruments convertible into or exchangeable for any debt or equity securities of the company or for any options or warrants therefor, or the acquisition, sale, lease, license or other disposition of the company or any material part of the equity or assets of the company or any other transaction that would prevent or impede the consummation of the transactions described herein and shall notify the investors promptly of 8 any inquiries by any third parties in regards to the foregoing (each an &#147; alternative transaction &#148;). if, at any time prior to expiration of the standstill period, the investors notify the company that they do not intend to proceed with the transaction substantially on the terms described herein, then the standstill period shall terminate at the time such notice is given and the company shall promptly file an 8-k to disclose such termination and notice. the company will, and the company will cause its representatives to, immediately terminate all such discussions or negotiations that may be in progress as of the date hereof and inform the investors of any expression of interest, inquiry, proposal, or offer regarding any alternative transaction received by the company, any stockholder of the company or any of its representatives during the standstill period. good faith efforts: the parties agree to work in good faith expeditiously towards a closing. information requests: the company agrees to provide the investors with the information necessary to complete a due diligence, operational and legal review satisfactory to the investors, including making its personnel, business, and financial books and records available to investors and their representatives. finders/brokers: none of the officers, directors or any equity holders of the company has engaged or used any &#147;finder&#148;, broker, agent or other person who is or may be entitled to any fee or other compensation with respect to (or as a result of the closing of) the transaction. governing law this term sheet shall be governed by and construed in accordance with the internal laws, and not the law of conflicts, of the state of nevada. expenses: whether or not the transactions contemplated herein are consummated, the company shall pay or reimburse all out-of-pocket expenses and disbursements incurred by the investors in connection with the transactions contemplated herein (including any securities law filings related thereto). if the closing occurs, then such reimbursement shall occur through the investors withholding such expenses and disbursements against a portion of the payment for the new preferred at closing, which withholding amount shall nevertheless constitute full payment of the purchase price therefor. following the closing, the company shall pay or reimburse any expenses or disbursements incurred by new preferred incurred in respect of (i) the enforcement of any such holder&#146;s rights vis-&agrave;-vis the company or otherwise under the definitive documents or any other agreement between such holder and the company, (ii) any amendment, modification or waiver in respect of 9 the definitive documents or any other agreement between such holder and the company, (iii) any additional investment in the company and (iv) any liquidity event. this term sheet may be withdrawn at any time by the investors set forth on the signature page hereto prior to the company&#146;s execution and delivery hereof to such investors. [signature page follows] 10 executed and delivered by each of the parties below (or its duly authorized officer) as of the date first written above. company: investors: agritech worldwide, inc. by: by: /s/ jonathan kahn name: name: jonathan kahn its: by: /s/ morris garfinkle name: morris garfinkle exhibit a post-closing capitalization table (on a fully-diluted basis) fully diluted ownership % common stock 5.0% existing preferred 6.0% notes* 14.0% new preferred 75.0% total 100.0% * notes also to receive $750,000 in cash. a-1 